Cargando…

Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma

Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of non-Hodgkin lymphoma, including various clinical manifestations, such as mycosis fungoides (MF) and Sézary syndrome (SS). CTCL mostly develops from CD4 T cells with the skin-tropic memory phenotype. Malignant T cells in MF lesions show the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakai, Shuichi, Kiyohara, Eiji, Watanabe, Rei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657644/ https://www.ncbi.nlm.nih.gov/pubmed/34884736 http://dx.doi.org/10.3390/ijms222312933

Ejemplares similares

Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
por: Kume, Miki, et al.
Publicado: (2021)

Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
por: Krejsgaard, Thorbjørn, et al.
Publicado: (2016)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
por: Cao, Severine, et al.
Publicado: (2017)

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis
por: Hirata, Chika, et al.
Publicado: (2022)

An overview of cutaneous T cell lymphomas
por: Bagherani, Nooshin, et al.
Publicado: (2016)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma
por: Kawai, Hidetsugu, et al.
Publicado: (2021)

Cutaneous T-Cell Lymphoma in Asians
por: Jang, Min Soo, et al.
Publicado: (2012)

Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
por: Huang, Hosea F, et al.
Publicado: (2005)

Romidepsin in the treatment of cutaneous T-cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2011)

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
por: Vadivel, Chella Krishna, et al.
Publicado: (2021)

B-Mode Ultrasound Imaging, Doppler Imaging, and Real-Time Elastography in Cutaneous Malignant Melanoma and Lymph Node Metastases
por: Uematsu, Takayoshi, et al.
Publicado: (2013)

Histology Resembling Cutaneous T-Cell Lymphoma in Nodular Scabies: A Case Report
por: Kataoka, Yukiko, et al.
Publicado: (2016)

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008)

Novel therapeutic agents for cutaneous T-Cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2012)

Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches
por: Tanase, Cristiana, et al.
Publicado: (2019)

Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
por: Licht, Philipp, et al.
Publicado: (2022)

Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
por: Pelcovits, Ari, et al.
Publicado: (2023)

Cutaneous T-cell lymphoma
por: Arora, Shalabh, et al.
Publicado: (2020)

Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma
por: Lauenborg, Britt, et al.
Publicado: (2015)

Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
por: Liu, Xiangjun, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
por: Dumont, Maëlle, et al.
Publicado: (2020)

Oral retinoids and rexinoids in cutaneous T-cell lymphomas
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2013)

Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
por: Fujimura, Taku, et al.
Publicado: (2021)

Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
por: Lai, Pan, et al.
Publicado: (2021)

Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma
por: Yumeen, Sara, et al.
Publicado: (2020)

Recent advances in understanding and managing cutaneous T-cell lymphomas
por: Brunner, Patrick M., et al.
Publicado: (2020)

The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas
por: Jost, Marion, et al.
Publicado: (2022)

Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4(+) T cells in cutaneous T-cell lymphoma
por: Blümel, Edda, et al.
Publicado: (2019)

Malignant T Cell Activation by a Bacillus Species Isolated from Cutaneous T-Cell Lymphoma Lesions
por: Dehner, Carina A., et al.
Publicado: (2021)

High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma
por: XU, Bufang, et al.
Publicado: (2021)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)
por: Hamada, Toshihisa, et al.
Publicado: (2019)

Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
por: Ion, Alexandra, et al.
Publicado: (2016)

The importance of assessing blood tumour burden in cutaneous T‐cell lymphoma
por: Vermeer, M.H., et al.
Publicado: (2021)

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
por: Duvic, Madeleine, et al.
Publicado: (2007)

Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
por: Willerslev-Olsen, Andreas, et al.
Publicado: (2013)

Cutaneous primary B-cell lymphomas: from diagnosis to treatment
por: Lima, Margarida
Publicado: (2015)

Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k0ld54fv9hi80mtje3itsdra2n